What Are Clinical Trials?

Clinical trials are structured research studies conducted in human participants to evaluate the safety, efficacy, and optimal use of medical interventions, including drugs, devices, biological products, surgical procedures, and behavioral treatments. The World Health Organization defines them as studies that evaluate the effects of an intervention on human health outcomes and distinguishes them from observational research by their prospective, experimental character. Trials are designed to generate controlled evidence capable of supporting or refuting specific hypotheses about a treatment's performance relative to a comparator, whether that is a placebo, a standard-of-care therapy, or no treatment.

The development of formalized trial methodology accelerated through the mid-twentieth century, with the 1948 randomized controlled trial of streptomycin for tuberculosis by the British Medical Research Council widely cited as an early model for modern trial design. Regulatory agencies including the U.S. Food and Drug Administration and the European Medicines Agency now require phased clinical trial evidence before approving most therapeutic interventions.

Trial Phases and Design

Clinical trials are organized into phases that reflect the maturity of evidence available and the objectives of each stage of evaluation. Phase I trials enroll small numbers of subjects (typically fewer than fifty) to determine a safe dosage range and characterize the pharmacokinetic and pharmacodynamic profile of a compound. Phase II trials expand participation to several hundred patients and focus on preliminary evidence of therapeutic effect and further safety characterization. Phase III trials are large-scale studies, often enrolling thousands of participants across multiple sites and countries, designed to confirm efficacy, compare outcomes against standard care, and gather data sufficient for regulatory submission. Phase IV trials, conducted after regulatory approval, monitor long-term safety, drug interactions, and performance in broader patient populations.

As reviewed in PMC's comprehensive analysis of clinical trial methodology, trial designs include parallel-group, crossover, factorial, and adaptive formats. Adaptive designs allow protocol modifications based on accumulating data without compromising the integrity of final inferences, making them valuable when early results challenge initial assumptions about dosing or patient stratification.

Randomization and Blinding

Randomization is the defining feature that distinguishes controlled trials from observational studies. Randomly assigning participants to intervention and control groups prevents selection bias and creates comparable groups before treatment begins, allowing differences in outcome to be attributed to the intervention rather than to pre-existing differences between participants. Blinding, in which participants and investigators are unaware of treatment assignment, reduces the influence of expectation on reported outcomes and on the conduct of assessments. Double-blind, randomized, placebo-controlled trials are widely considered the highest standard for evaluating therapeutic interventions.

Statistical analysis plans, pre-registered before data collection begins, specify the primary and secondary endpoints and the analytical methods to be used, protecting against post-hoc modifications that could inflate false-positive findings.

Ethics and Regulatory Oversight

Clinical trial conduct is governed by the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice guidelines, and national regulatory frameworks. Institutional review boards and ethics committees review protocols before recruitment begins, assessing scientific merit, participant protection measures, and the risk-benefit balance. Informed consent is mandatory: participants must understand the nature of the study, the risks involved, and their right to withdraw at any point.

The U.S. National Institutes of Health ClinicalTrials.gov registry serves as the primary public database for trial registration and results reporting, with registration now required by law for most interventional studies in the United States.

Applications

Clinical trials have applications in a wide range of fields, including:

• Pharmaceutical development for new drug approvals
• Medical device evaluation for implantable and diagnostic technologies
• Cancer treatment optimization through oncology trial networks
• Vaccine efficacy and safety assessment for infectious disease prevention
• Behavioral and surgical intervention research in mental health and surgery